Clinical Research Directory
Browse clinical research sites, groups, and studies.
Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma.
Sponsor: Associazione Angela Serra per la ricerca sul cancro
Summary
This study T-Cell Project 2.0 is based on the former International PTCL study designed by the International T-cell Non-Hodgkin's Lymphoma Study Group (T-Cell Project 1.0: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma) as a prospective collection of data to predict the prognosis of patients with the more frequent subtypes of PTCL. It is a prospective, longitudinal, international, observational study of patients with newly diagnosed peripheral T-cell lymphoma aiming to verify whether this prospective collection of data would allow achieving a more accurate information on T-cell lymphomas. The study aims to better define the clinical relevance of the new WHO Classification, the role of FDG-PET in staging and response assessment, the prognosis of different entities, the genomic landscape of different subtypes, and to investigate on most optimal treatment strategies for these neoplasms in the real-world population as well as molecular markers and to explore the prognostic or predictive implications of them in PTCL. The study aims to better define the clinical relevance of the new WHO Classification, the role of FDG-PET in staging and response assessment, the prognosis of different entities, the genomic landscape of different subtypes, and to investigate on most optimal treatment strategies for these neoplasms in the real-world population.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1000
Start Date
2018-10-14
Completion Date
2025-07-30
Last Updated
2025-05-06
Healthy Volunteers
No
Conditions
Locations (6)
Stanford University
Stanford, California, United States
IRCCS Istituto Tumori "Giovanni Paolo II"
Bari, Italy
Palermo_La Maddalena
Palermo, Italy
Terni-Santa Maria
Terni, Italy
Cluj Napoca_Ion Chiricuta Oncology Institute
Cluj-Napoca, Romania
National Cancer Institute
Kiev, Ukraine